{"transactions":[{"id":1579957,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":89580,"kind":"person","name":"Cavalie Fanny","position":1,"cik":"0001913484","reported_name":"Cavalie Fanny","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy/Bus Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-12T20:19:27.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":11000,"price":6.5576,"value":72133.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $6.50 USD to $6.83 USD; the price reported above reflects the weighted average sale price."}],"balance_after":75992,"source":{"system":"sec-edgar","filing":"0001562180-24-002591","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024002591/primarydocument.xml","form_type":"4"}},{"id":1670624,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":89580,"kind":"person","name":"Cavalie Fanny","position":1,"cik":"0001913484","reported_name":"Cavalie Fanny","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy/Bus Ops Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-25T21:03:46.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":3.06,"value":244800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":80000,"derivative":{"exercise_price":3.06,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-24-000608","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024000608/primarydocument.xml","form_type":"4"}},{"id":2041766,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":89580,"kind":"person","name":"Cavalie Fanny","position":1,"cik":"0001913484","reported_name":"Cavalie Fanny","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy/Bus Ops Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-30T22:04:23.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":65000,"derivative":{"exercise_price":8.38,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-23-000727","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023000727/primarydocument.xml","form_type":"4"}}]}